851.61MMarket Cap-7608P/E (TTM)
13.4351High12.4000Low1.05MVolume13.4100Open13.3500Pre Close13.54MTurnover2.42%Turnover RatioLossP/E (Static)67.43MShares19.050052wk High2.50P/B547.61MFloat Cap2.201052wk Low--Dividend TTM43.36MShs Float85.0000Historical High--Div YieldTTM7.75%Amplitude0.0300Historical Low12.8960Avg Price1Lot Size
Perspective Therapeutics Stock Forum
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...
No comment yet